These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2983805)

  • 21. Electrophysiological studies of neuromuscular transmission in hereditary 'motor end-plate disease' of the mouse.
    Duchen LW; Stefani E
    J Physiol; 1971 Jan; 212(2):535-48. PubMed ID: 4323310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disorders of neuromuscular transmission other than myasthenia gravis.
    Swift TR
    Muscle Nerve; 1981; 4(4):334-53. PubMed ID: 6114428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity-driven synaptic and axonal degeneration in canine motor neuron disease.
    Carrasco DI; Rich MM; Wang Q; Cope TC; Pinter MJ
    J Neurophysiol; 2004 Aug; 92(2):1175-81. PubMed ID: 15028742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The neuromuscular basis of hereditary kyphoscoliosis in the mouse.
    Bridges LR; Coulton GR; Howard G; Moss J; Mason RM
    Muscle Nerve; 1992 Feb; 15(2):172-9. PubMed ID: 1372391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Motoneuron death and motor unit size during embryonic development of the rat.
    Harris AJ; McCaig CD
    J Neurosci; 1984 Jan; 4(1):13-24. PubMed ID: 6693936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Some factors affecting spontaneous transmitter release in dystrophic mice.
    Shalton PM; Wareham AC
    Muscle Nerve; 1980; 3(2):120-7. PubMed ID: 6154237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dolichos biflorus agglutinin receptors in mouse muscle. I. Developmental expression in relation to synaptic acetylcholinesterase and to neuromuscular disease.
    Kaupmann K; Heimann P; Jockusch H
    Eur J Cell Biol; 1988 Aug; 46(3):411-8. PubMed ID: 3181163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rab3A deletion selectively reduces spontaneous neurotransmitter release at the mouse neuromuscular synapse.
    Sons MS; Plomp JJ
    Brain Res; 2006 May; 1089(1):126-34. PubMed ID: 16631140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three types of transmitter release from embryonic neurons.
    Poo MM; Sun YA; Young SH
    J Physiol (Paris); 1985; 80(4):283-9. PubMed ID: 3009797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mouse model for congenital myasthenic syndrome due to MuSK mutations reveals defects in structure and function of neuromuscular junctions.
    Chevessier F; Girard E; Molgó J; Bartling S; Koenig J; Hantaï D; Witzemann V
    Hum Mol Genet; 2008 Nov; 17(22):3577-95. PubMed ID: 18718936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciliary neurotrophic factor is required for motoneuron sprouting.
    Siegel SG; Patton B; English AW
    Exp Neurol; 2000 Dec; 166(2):205-12. PubMed ID: 11085886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of trifluoperazine and promethazine on the release of transmitter quanta at the mouse neuromuscular junction.
    Nishimura M; Komatsu R; Taquahashi Y; Shimizu Y; Satoh E
    J Peripher Nerv Syst; 1998; 3(2):111-5. PubMed ID: 10959244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4-aminopyridine-a review.
    Soni N; Kam P
    Anaesth Intensive Care; 1982 May; 10(2):120-6. PubMed ID: 6285756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonism of the ruthenium red-induced paralysis in mice by 4-aminopyridine, guanidine and lanthanum.
    Tapia R
    Neurosci Lett; 1982 May; 30(1):73-7. PubMed ID: 6179018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscular dystrophy in the mouse: neuromuscular transmission and the concept of functional denervation.
    Harris JB; Ribchester RR
    Ann N Y Acad Sci; 1979; 317():152-70. PubMed ID: 38724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental foundations of EMG biofeedback with the upper extremity: a review of the literature.
    Ince LP; Leon MS; Christidis D
    Biofeedback Self Regul; 1984 Sep; 9(3):371-83. PubMed ID: 6525360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphological relationships between motor end-plate localization and the vascular bed of skeletal muscle.
    Stingl J; Parízek J
    Folia Morphol (Praha); 1978; 26(3):239-42. PubMed ID: 700534
    [No Abstract]   [Full Text] [Related]  

  • 38. Hereditary motor endplate disease (med) of the mouse: observations on dissociated myogenic cells and their development in culture.
    Jockusch H; Burkart W; Burger MM
    Cell Tissue Res; 1980; 207(2):241-8. PubMed ID: 7388917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neostigmine myopathy is a calcium ion-mediated myopathy initially affecting the motor end-plate.
    Kawabuchi M
    J Neuropathol Exp Neurol; 1982 May; 41(3):298-314. PubMed ID: 6804607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrovirus-induced motor neuron disease of mice: molecular basis of neurotropism and paralysis.
    Jolicoeur P; Rassart E; DesGroseillers L; Robitaille Y; Paquette Y; Kay DG
    Adv Neurol; 1991; 56():481-93. PubMed ID: 1649546
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.